TDO2
protein-codingtryptophan 2,3-dioxygenase
Gene summary
This gene encodes a heme enzyme that plays a critical role in tryptophan metabolism by catalyzing the first and rate-limiting step of the kynurenine pathway. Increased activity of the encoded protein and subsequent kynurenine production may also play a role in cancer through the suppression of antitumor immune responses, and single nucleotide polymorphisms in this gene may be associated with autism. [provided by RefSeq, Feb 2012]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~65.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0010907
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0010907
Submitter: PanelApp Australia
Inheritance Pattern: Unknown
Disease ID:MONDO:0010907
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0010907
Submitter: ClinGen
*TDO2* was first reported in relation to autosomal recessive hypertryptophanemia in 2017 (Ferreira P, et al., 2017, PMID: 28285122). It results in the biochemical phenotype of persistent hypertryptophanemia and hyperserotoninemia, but without any discernable clinical phenotype. Unbiased ascertainment by newborn screening strongly suggests that this is a benign biochemical variant of no clinical significance (PMIDs: 28285122). Evidence supporting this gene-disease relationship includes case-level data and experimental data. Two unique variants (missense and frameshift) have been reported in the single human case (PMID: 28285122). This gene-disease association is supported by its biochemical function in tryptophan metabolism (PMID: 18027945) and a knockout mouse model (PMID: 19323847). In summary, there is limited evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This gene-disease pair was previously evaluated by the Aminoacidopathy GCEP on 07/10/2020. It was reevaluated on 10/24/2023. As a result of this reevaluation, the classification remained Limited with no new evidence identified.
Clinical Genomic Database (CGD)
Manifestation: Biochemical
Intervention: General
Rationale: The clinical relevance of the condition is unclear
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to TDO2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_005651.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 1 | 3 | |||
| missense | 51 | 1 | 1 | 53 | ||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 1 | 1 | ||||
| splice donor/acceptor (+/-2bp) | 1 | 1 | ||||
| Total | 0 | 0 | 53 | 3 | 2 | 58 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_005642.1 | 12 | MANE Select | |
| Ensembl | ENSP00000444788.2 | 12 | MANE Select | |
| Ensembl | ENSP00000423394.1 | 2 | Standard | |
| Ensembl | ENSP00000424384.1 | 2 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Tryptophan metabolism - Homo sapiens (human)
- Tryptophan Metabolism
- NAD Biosynthesis II (from tryptophan)
- NAD+ biosynthetic pathways
- Amino Acid metabolism
Biological Process
- tryptophan catabolic process
- tryptophan catabolic process to kynurenine
- tryptophan catabolic process to acetyl-CoA
- protein homotetramerization
- oxidation-reduction process
Molecular Function
- tryptophan 2,3-dioxygenase activity
- protein binding
- amino acid binding
- oxygen binding
- heme binding
Cellular Component
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000536354
- Coding exons
- 12
- Length
- 65669
- Individuals with no LoFs
- 125653
- Homozygous LoFs
- 1
- Heterozygous LoFs
- 94
- Defined
- 125748
- p
- 0.000378
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.221 | 210 | 201 | 1.04 | 0.00000987 | 2651 |
| Missense (PolyPhen) | 91 | 72.899 | 1.2483 | 952 | ||
| Synonymous | -0.303 | 77 | 73.7 | 1.04 | 0.00000357 | 718 |
| Loss of Function | 1.40 | 19 | 26.8 | 0.708 | 0.00000156 | 316 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00018 | 0.00018 | rare |
| Latino/Admixed American | 0.00050 | 0.00049 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00033 | 0.00033 | rare |
| Finnish | 0.00019 | 0.00018 | rare |
| European (Non-Finnish) | 0.00048 | 0.00047 | rare |
| South Asian | 0.00031 | 0.00026 | rare |
| Other | 0.00065 | 0.00065 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Heme-dependent dioxygenase that catalyzes the oxidative cleavage of the L-tryptophan (L-Trp) pyrrole ring and converts L- tryptophan to N-formyl-L-kynurenine. Catalyzes the oxidative cleavage of the indole moiety. {ECO:0000255|HAMAP-Rule:MF_03020, ECO:0000269|PubMed:25066423, ECO:0000269|PubMed:27762317, ECO:0000269|PubMed:28285122}.;
- Disease
- DISEASE: Hypertryptophanemia (HYPTRP) [MIM:600627]: An autosomal recessive condition characterized by persistent hypertryptophanemia and hyperserotoninemia. {ECO:0000269|PubMed:28285122}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.359
Intolerance Scores
- LoFtool
- 0.387
- RVIS EVS
- 0
- RVIS percentile EVS
- 53.73
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.754
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |